Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment
Open Access
- 23 February 2009
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 20 (6) , 1080-1085
Abstract
Background: Hepatosplenic T-cell lymphoma (HSTCL) is a rare peripheral T-cell lymphoma; treatment with standard anthracycline-containing chemotherapy regimens has been disappointing, and an optimal treatment strategy for this patient population has not yet been determined. Methods: We identified 15 cases of pathologically confirmed HSTCL in the institution's database. Clinical characteristics and treatment results were reviewed. Results: Complete responses (CRs) were achieved in 7 of 14 patients who received chemotherapy. Achievement of CR was followed by hematopoietic stem-cell transplantation in three patients. Median duration of CR was 8 months (range 2 to 32+ months) with four patients currently alive and in CR at 5, 8, 12, and 32 months, respectively. Median overall survival (OS) was 11 months (range 2 to 36+ months). Patients who achieved a CR had a median OS of 13 months, compared with 7.5 months in patients who did not achieve a CR. Risk factors associated with worse outcome included male gender, failure to achieve a CR, history of immunocompromise, and absence of a T-cell receptor gene rearrangement in the gamma chain. Conclusion: A better understanding of the pathophysiology of HSTCL and new therapeutic strategies are needed.Keywords
This publication has 33 references indexed in Scilit:
- Hepatosplenic γδ T‐cell lymphoma following seven malaria infectionsPathology International, 2006
- Hepatosplenic T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsBlood, 2003
- Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T‐cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progressionGenes, Chromosomes and Cancer, 2001
- Hepatosplenic gamma/delta T-Cell Lymphoma in Immunocompromised PatientsAmerican Journal of Clinical Pathology, 2001
- Hepatosplenic αβ T-Cell LymphomaAmerican Journal of Surgical Pathology, 2000
- Hepatosplenic gamma-delta T-Cell Lymphoma as a Late-Onset Posttransplant Lymphoproliferative Disorder in Renal Transplant RecipientsAmerican Journal of Clinical Pathology, 2000
- Hepatosplenic T-Cell Lymphoma of αβ Lineage in a 16-Year-Old Boy Presenting With Hemolytic Anemia and ThrombocytopeniaAmerican Journal of Surgical Pathology, 2000
- Consistency of Isochromosome 7q and Trisomy 8 in Hepatosplenic γδ T-cell Lymphoma: Detection by Fluorescence in Situ Hybridization of a Splenic Touch-Preparation from a Pediatric PatientPediatric and Developmental Pathology, 1999
- Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic γδ T cell lymphomaLeukemia, 1997
- Consistent presence of isochromosome 7q in hepatosplenic t γ/δ lymphoma: A new cytogenetic‐clinicopathologic entityGenes, Chromosomes and Cancer, 1995